000 | 00983 a2200241 4500 | ||
---|---|---|---|
005 | 20250518083314.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a2515-2092 | ||
024 | 7 |
_a10.1093/jcag/gwz035 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoayyedi, Paul | |
245 | 0 | 0 |
_aJoint Canadian Association of Gastroenterology and Crohn's Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease. _h[electronic resource] |
260 |
_bJournal of the Canadian Association of Gastroenterology _cFeb 2020 |
||
300 |
_ae1-e9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aBenchimol, Eric I | |
700 | 1 | _aArmstrong, David | |
700 | 1 | _aYuan, Cathy | |
700 | 1 | _aFernandes, Aida | |
700 | 1 | _aLeontiadis, Grigorios I | |
773 | 0 |
_tJournal of the Canadian Association of Gastroenterology _gvol. 3 _gno. 1 _gp. e1-e9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jcag/gwz035 _zAvailable from publisher's website |
999 |
_c30588813 _d30588813 |